Cargando…
The Immunopathology of COVID-19 and the Cannabis Paradigm
Coronavirus disease-19 caused by the novel RNA betacoronavirus SARS-CoV2 has first emerged in Wuhan, China in December 2019, and since then developed into a worldwide pandemic with >99 million people afflicted and >2.1 million fatal outcomes as of 24th January 2021. SARS-CoV2 targets the lower...
Autores principales: | Paland, Nicole, Pechkovsky, Antonina, Aswad, Miran, Hamza, Haya, Popov, Tania, Shahar, Eduardo, Louria-Hayon, Igal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907157/ https://www.ncbi.nlm.nih.gov/pubmed/33643316 http://dx.doi.org/10.3389/fimmu.2021.631233 |
Ejemplares similares
-
Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions
por: Paland, Nicole, et al.
Publicado: (2023) -
High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs
por: Aswad, Miran, et al.
Publicado: (2022) -
Signal, Transduction, and the Hematopoietic Stem Cell
por: Louria-Hayon, Igal
Publicado: (2014) -
The heterogeneity and complexity of Cannabis extracts as antitumor agents
por: Baram, Liran, et al.
Publicado: (2019) -
Antitumoral effects of cannabis in Notch1‐mutated T‐cell acute lymphoblastic leukemia
por: Besser, Elazar, et al.
Publicado: (2023)